PHOTO: Chengdongshan / Shutterstock.com
An educational webinar for veterinarians about CBD products and use of cannabidiol (CBD) products for pets with various medical conditions was presented by Dr. Zac Pilossoph, chief medical officer for Cansultants, Inc.
Sponsored by the National Cannabis Industry Association (NCIA) on its YouTube channel, Dr. Pilossoph also discussed the status of medical cannabis recommendations for veterinarians in the U.S. The presentation was titled, “The Cannabis Pet Industry: What’s to Know and What’s for Show.”
The presentation started off with a primer on the endocannabinoid system, which Pilossoph said, should be thought of as a “homeostatic regulator system” found in humans and “chordates,” or animals with a spine—including animals such as horses, birds, and reptiles that often are overlooked when CBD treatment for pets is considered.
Dr. Pilossoph commented that one of the reasons he took up education around cannabis-based medicines and their use in veterinary treatment was because he felt frustration from not having learned about the endocannabinoid system earlier, and the lack of instruction available to medical students and doctors.
“I felt frustrated, how I’d never learned this in school,” he explained.
Going on to cite published studies about the effects of CBD (and cannabis-based medicines), Pilossoph said there have been several studies, going back to the 1980s, that show cannabis had beneficial effects for several conditions including glaucoma, inflammation, and nausea, as well as having proven anti-bacterial properties.
In veterinary medicine, studies of cannabis- or hemp-based treatments are hard to find, but a wealth of anecdotal evidence has presented, as pet owners attest to the results they have seen when self-treating pets with CBD.
Pilossoph noted that such a trend among pet owners, by itself, should encourage more clinical studies to be conducted to identify the beneficial components in CBD (and other plant compounds). He added that a there have been studies conducted on dogs that indicated CBD could provide anti-inflammatory benefits for osteoarthritis and seizures.
Other plant compounds that work in synergy with cannabinoids create the “entourage effect,” Pilossoph said further. Terpenes and flavonoids, he said, seem to enhance the effects of cannabinoids in cannabis- and hemp-based medications.
“The entourage effect exists,” he said, which would suggest that “full-spectrum” formulations might provide greater therapeutic benefits.
Pilossoph hoped that product manufacturers would “harness the power of raw hemp,” as a resource